San Diego, USA – Department of Health – Abu Dhabi has signed a strategic partnership agreement with Biocom California. One of the world’s largest life sciences associations representing more than 1,800 institutions in the fields of biotechnology, pharmaceuticals, and medical technologies. This strengthens Abu Dhabi’s position as a global center for health and life sciences innovation, linking the life sciences systems in Abu Dhabi and California. To support and accelerate health innovation globally.
The partnership aims to enhance cooperation and communication between innovators, researchers, investors and entrepreneurs on both sides. This opens new opportunities to accelerate the development, validation, and scale-up of the next generation of health solutions. In addition to supporting the exchange of expertise within the life sciences system and developing complexes concerned with this vital sector.
Exchange global practices
The two parties will work to exchange global best practices, regulatory insights, and lessons learned from pioneering experiences. This contributes to enhancing innovation environments and supporting the growth of the life sciences sector in both Abu Dhabi and California. The partnership will connect California’s global life sciences ecosystem with the Health, Medicine & Fitness for Sustainable Living complex in Abu Dhabi. This provides companies with broader opportunities to develop, innovate and test across both markets.
Through Biocom California, biotechnology, pharmaceutical and medical technology companies in the United States will have access to Abu Dhabi’s smart life sciences system. Its innovative model combines scientific discovery, clinical experience, and real-world application within an integrated environment that accelerates the transformation of knowledge into tangible health solutions.
Cooperation supports the organization of joint events, the reception of delegations, and the implementation of specialized initiatives focused on developing competencies. Capacity building is a key focus of this partnership. Reflecting a shared commitment to developing the advanced talents, expertise, and skills needed to support the growth of the life sciences sector.
Review experiences and partnerships
The agreement was signed as part of Abu Dhabi’s participation in the Biotechnology Innovation Organization’s 2026 World Conference. Held in San Diego, USA. The emirate showcases its intelligent life sciences system and partnerships in the fields of genomics and gene editing. Health innovation powered by artificial intelligence, advanced treatments, and rare diseases.
The Department of Health – Abu Dhabi delegation to the United States includes an elite group of the most prominent actors in the health, investment and innovation system in the emirate. Including Abu Dhabi Investment Office, M42, Hub71, NYU Abu Dhabi, Masdar City, and Khalifa University. Kizad Group, PureHealth, Mubadala Bio, Arcera, and the Healthy Living Institute in Abu Dhabi.
